anmelden
SLI
2.304,26
PKT
-14,05
PKT
-0,61
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.09.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.09.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 22.09.22 | Nestlé Neutral | Credit Suisse Group | |
| 22.09.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 21.09.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 21.09.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 21.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.09.22 | Roche Hold | Deutsche Bank AG | |
| 21.09.22 | Novartis Sell | Deutsche Bank AG | |
| 21.09.22 | UBS Sector Perform | RBC Capital Markets | |
| 20.09.22 | Richemont Overweight | JP Morgan Chase & Co. | |
| 16.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 15.09.22 | Swiss Re Sell | UBS AG | |
| 15.09.22 | Novartis Underperform | Credit Suisse Group | |
| 15.09.22 | Roche Outperform | Credit Suisse Group | |
| 15.09.22 | Givaudan Underperform | Bernstein Research | |
| 15.09.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 14.09.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 14.09.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 14.09.22 | UBS Outperform | Credit Suisse Group | |
| 14.09.22 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.09.22 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.09.22 | UBS Buy | Jefferies & Company Inc. | |
| 13.09.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.09.22 | Roche Hold | Deutsche Bank AG | |
| 13.09.22 | Roche Outperform | Bernstein Research | |
| 13.09.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 13.09.22 | Holcim Neutral | JP Morgan Chase & Co. | |
| 12.09.22 | Givaudan Underperform | Bernstein Research | |
| 12.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.09.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.09.22 | Roche Hold | Deutsche Bank AG | |
| 09.09.22 | Richemont Overweight | Barclays Capital | |
| 09.09.22 | Swiss Re Equal Weight | Barclays Capital | |
| 08.09.22 | Richemont Market-Perform | Bernstein Research | |
| 08.09.22 | Zurich Insurance Overweight | Barclays Capital | |
| 08.09.22 | Roche Buy | Jefferies & Company Inc. | |
| 07.09.22 | Swiss Re Sell | UBS AG | |
| 07.09.22 | Zurich Insurance Buy | UBS AG | |
| 07.09.22 | UBS Neutral | UBS AG |
